SILO Rentabilitas reged Silo Pharma, Inc.

Silo Pharma, Inc. (SILO) operates in the mental health niche, facing revenue deficits and a reliance on investment. On GURU.Markets, the actual gross margin is available as a trend, and this metric has reached the level of -1356.70. Growth potential is driven by academic partnerships to develop dementia therapies and professional management focused on clinical trial transparency and regulatory standards.
Rincian metrik keuangan lan pasar Silo Pharma (SILO)

High R&D expenditures and patent protection for Silo Pharma, Inc. (SILO) subnasal products drive gross margin volatility. This indicator captures the portion of revenue remaining after covering direct production costs, reflecting the business's operational efficiency. The percentage difference between total revenue and the cost of goods sold allows for an assessment of the fundamental stability of this high-risk biopharmaceutical asset.